Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

3′UTR heterogeneity and cancer progression
Jia Jia Chan, Hossein Tabatabaeian, Yvonne Tay
Trends in Cell Biology (2022) Vol. 33, Iss. 7, pp. 568-582
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

N6-methyladenosine-mediated gene regulation and therapeutic implications
Yujiao Liu, Dan Yang, Tao Liu, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 6, pp. 454-467
Closed Access | Times Cited: 62
Coding, or non-coding, that is the question
Laura Poliseno, Martina Lanza, Pier Paolo Pandolfi
Cell Research (2024) Vol. 34, Iss. 9, pp. 609-629
Open Access | Times Cited: 20
3’UTR Diversity: Expanding Repertoire of RNA Alterations in Human mRNAs
Dawon Hong, Sunjoo Jeong
Molecules and Cells (2023) Vol. 46, Iss. 1, pp. 48-56
Open Access | Times Cited: 37
Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions
Mark P. Purdue, Diptavo Dutta, Mitchell J. Machiela, et al.
Nature Genetics (2024) Vol. 56, Iss. 5, pp. 809-818
Closed Access | Times Cited: 10
The role of ADAR1 through and beyond its editing activity in cancer
Yue Jiao, Yuqin Xu, Chengbin Liu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Enhancing mRNA translation efficiency by introducing sequence optimized AU rich elements in 3’UTR via HuR anchorage
Xinghuan Ma, S W Liu, Bangda Fan, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 2, pp. 102485-102485
Open Access | Times Cited: 1
Competing endogenous RNAs (ceRNAs) and drug resistance to cancer therapy
Kenneth K.W. To, Hang Zhang, William C. Cho
Cancer Drug Resistance (2024)
Open Access | Times Cited: 5
Autoimmune disease: a view of epigenetics and therapeutic targeting
S. Y. Mu, Wanrong Wang, Qiuyu Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Identification of rare and pathogenic TAL2 gene mutations in B-lineage acute lymphoblastic leukemia (B-ALL) using mutational screening and comprehensive bioinformatics analysis
Fateme Zare Khormizi, H. Saadi, Mehri Khatami, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Multiple regulatory events contribute to a widespread circular RNA downregulation in precancer and early stage of colorectal cancer development
Alessandro Camandona, Amedeo Gagliardi, Nicola Licheri, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
The Druggable Transcriptome Project: From Chemical Probes to Precision Medicines
Matthew D. Disney
Biochemistry (2025)
Closed Access
The power of microRNA regulation—insights into immunity and metabolism
Stefania Oliveto, Nicola Manfrini, Stefano Biffo
FEBS Letters (2025)
Open Access
IGF2BP3 recruits NUDT21 to regulate SPTBN1 alternative polyadenylation and drive ovarian cancer progression
Xin Luo, Lingcui Xie, Xiaohui Ma, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Unveiling RNA Editing by ADAR and APOBEC Protein Gene Families
Alexander Modestov, Anton Buzdin, Maria Suntsova
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 4
Open Access
3′ untranslated region somatic variants connect alternative polyadenylation dysregulation in human cancers
Qiushi Xu, Xiaomeng Cheng, Qianru Li, et al.
Journal of genetics and genomics/Journal of Genetics and Genomics (2025)
Closed Access
Genetic Regulation of Alternative Polyadenylation Provides Novel Insights into Molecular Mechanisms Underlying Non‐small Cell Lung Cancer
Meng Jin, Yongbiao Huang, Bin Li, et al.
Advanced Science (2025)
Open Access
Post-Transcriptional Regulation of Diabetic Wound Healing by Junctional Adhesion Molecule A/miR-106b axis
藤森 功, Xiaoming Fan, Minjuan Wu, et al.
Burns (2025), pp. 107527-107527
Closed Access
Roles for epithelial integrin α3β1 in regulation of the microenvironment during normal and pathological tissue remodeling
Rakshitha Pandulal Miskin, C. Michael DiPersio
AJP Cell Physiology (2024) Vol. 326, Iss. 5, pp. C1308-C1319
Closed Access | Times Cited: 3
YY1 is regulated by ALKBH5-mediated m6A modification and promotes autophagy and cancer progression through targeting ATG4B
Shijiang Wang, Jiangbo Nie, Kaiying Xu, et al.
Aging (2023) Vol. 15, Iss. 18, pp. 9590-9613
Open Access | Times Cited: 7
Gastrointestinal cancer cells with Pt-resistance and relationship with aberrant expression of long non-coding RNAs
Valeria Ferretti, Kameron L. Klugh, Kaitlin A. Doucette, et al.
Coordination Chemistry Reviews (2024) Vol. 509, pp. 215791-215791
Closed Access | Times Cited: 2
R-loops’ m6A modification and its roles in cancers
Yue Qiu, Changfeng Man, Luyu Zhu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Association of SOD2 rs2758339, rs5746136 and rs2842980 polymorphisms with increased risk of breast cancer: a haplotype-based case–control study
Sara Asadi, Morteza Abkar, Zahra Zamanzadeh, et al.
Genes & Genomics (2023) Vol. 45, Iss. 9, pp. 1165-1178
Closed Access | Times Cited: 5
The 3′ UTR of vigR is required for virulence in Staphylococcus aureus and has expanded through STAR sequence repeat insertions
Daniel G. Mediati, William Dan, David Lalaouna, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114082-114082
Open Access | Times Cited: 1
HuR facilitates miR-93-5p-induced activation of MAP3K2 translation via MAP3K2 3’UTR ARE2 in hepatocellular carcinoma
Xuan Shi, Zhuoran Qi, Dongbo Huang, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 722, pp. 150152-150152
Closed Access | Times Cited: 1
Association of 3'UTR variations of EGFR and KRAS oncogenes with clinical parameters in lung cancer tumours
Özkan Bağcı
Biology of the Cell (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top